Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 90 for transplant

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study to Verify the Application of Lung Ultrasound Artefact Analysis for Exclusion of Acute Rejection in Asymptomatic Lung Transplant Recipients

    Jacksonville, FL

  2. A Study to Evaluate Posoleucel ALVR105 to Treat Kidney Transplant Recipients with BK Viremia

    Scottsdale/Phoenix, AZ

  3. Adipose-derived MSC to Treat Rejection in Kidney Transplant Recipients

    Rochester, MN

  4. A Study to Evaluate the Effectiveness and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients

    Rochester, MN

  5. Mediterranean Diet Post-liver Transplantation

    Rochester, MN

  6. A Trial of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation

    Rochester, MN, Jacksonville, FL

  7. Physical Activity Intervention for Hematopoietic Cell Transplant Recipients and Caregivers

    Scottsdale/Phoenix, AZ

  8. A Study of Ibrutinib as Prophylaxis for Chronic Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (allo-HCT)

    Jacksonville, FL

  9. Pre-transplant Health Coaching to Improve Patient-Reported Outcomes in Lung Transplant Candidates

    Rochester, MN, Jacksonville, FL

  10. A Study to Evaluate the Effect of Inspiratory Muscle Training on Physiological Function and Clinical Outcomes Following Lung Transplant

    Jacksonville, FL

.

Mayo Clinic Footer